Does lY294002 potentiate the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway?
Combination of oxaliplatin and LY294002 was therapeutically promising for gastric cancer treatment. The enhanced sensitivity of the combined treatment was associated with the activation of the death receptor pathway.
In the current climate, schools are compelled to make strategic decisions regarding the configuration of clinical teaching in a context where healthcare is also increasingly centralised. However, it is clear that smaller hospitals are preferred by students.